Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Inventory Average (2020 - 2025)

Historic Inventory Average for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to $6.7 million.

  • Harmony Biosciences Holdings' Inventory Average rose 599.62% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 599.62%. This contributed to the annual value of $6.3 million for FY2024, which is 2220.06% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Inventory Average stood at $6.7 million, which was up 599.62% from $6.4 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Inventory Average high stood at $7.1 million for Q4 2024, and its period low was $4.4 million during Q1 2021.
  • Over the past 5 years, Harmony Biosciences Holdings' median Inventory Average value was $5.2 million (recorded in 2021), while the average stood at $5.5 million.
  • In the last 5 years, Harmony Biosciences Holdings' Inventory Average surged by 5913.88% in 2021 and then tumbled by 1093.8% in 2022.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Inventory Average stood at $5.1 million in 2021, then fell by 6.58% to $4.7 million in 2022, then grew by 13.52% to $5.4 million in 2023, then skyrocketed by 31.42% to $7.1 million in 2024, then dropped by 5.68% to $6.7 million in 2025.
  • Its Inventory Average stands at $6.7 million for Q3 2025, versus $6.4 million for Q2 2025 and $6.9 million for Q1 2025.